| Literature DB >> 21647293 |
Brandon Sj Davies1, Catherine Coffinier, Shao H Yang, Richard H Barnes, Hea-Jin Jung, Stephen G Young, Loren G Fong.
Abstract
Lmna yields two major protein products in somatic cells, lamin C and prelamin A. Mature lamin A is produced from prelamin A by four posttranslational processing steps-farnesylation of a carboxyl-terminal cysteine, release of the last three amino acids of the protein, methylation of the farnesylcysteine, and the endoproteolytic release of the carboxyl-terminal 15 amino acids of the protein (including the farnesylcysteine methyl ester). Although the posttranslational processing of prelamin A has been conserved in vertebrate evolution, its physiologic significance remains unclear. Here we review recent studies in which we investigated prelamin A processing with Lmna knock-in mice that produce exclusively prelamin A (Lmna(PLAO)), mature lamin A (Lmna(LAO)) or nonfarnesylated prelamin A (Lmna(nPLAO)). We found that the synthesis of lamin C is dispensable in laboratory mice, that the direct production of mature lamin A (completely bypassing all prelamin A processing) causes no discernable pathology in mice, and that exclusive production of nonfarnesylated prelamin A leads to cardiomyopathy.Entities:
Keywords: cardiomyopathy; prelamin A; progeria; protein farnesylation; restrictive dermopathy
Mesh:
Substances:
Year: 2011 PMID: 21647293 PMCID: PMC3104803 DOI: 10.4161/nucl.2.1.13723
Source DB: PubMed Journal: Nucleus ISSN: 1949-1034 Impact factor: 4.197